Hokuyaku Takeyama HoldingsInc Management
Management criteria checks 0/4
Hokuyaku Takeyama HoldingsInc's CEO is Masanobu Manabe, appointed in Jun 2018, has a tenure of 6.42 years. directly owns 0.11% of the company’s shares, worth ¥20.26M. The average tenure of the management team and the board of directors is 1.8 years and 1.8 years respectively.
Key information
Masanobu Manabe
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.4yrs |
| CEO ownership | 0.1% |
| Management average tenure | 1.8yrs |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
Does Hokuyaku Takeyama Holdings,Inc. (SPSE:3055) Have A Place In Your Dividend Portfolio?
Apr 15
What Kind Of Shareholders Hold The Majority In Hokuyaku Takeyama Holdings,Inc.'s (SPSE:3055) Shares?
Mar 08Will Hokuyaku Takeyama HoldingsInc (SPSE:3055) Multiply In Value Going Forward?
Feb 15Are Hokuyaku Takeyama HoldingsInc's (SPSE:3055) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 28Does Hokuyaku Takeyama Holdings,Inc. (SPSE:3055) Have A Place In Your Dividend Portfolio?
Jan 10
Introducing Hokuyaku Takeyama HoldingsInc (SPSE:3055), A Stock That Climbed 14% In The Last Five Years
Dec 23What Type Of Shareholders Own The Most Number of Hokuyaku Takeyama Holdings,Inc. (SPSE:3055) Shares?
Dec 05CEO
Masanobu Manabe (58 yo)
6.4yrs
Tenure
Mr. Masanobu Manabe had been Vice President and Administrator of Pharmaceutical Business of Hokuyaku Takeyama Holdings Inc., since June 2014 and June 2015 respectively. Mr. Manabe served as a Senior Managi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.4yrs | no data | 0.11% ¥ 20.3m | |
| ICT Business Manager | less than a year | no data | 1.76% ¥ 312.3m | |
| Executive Officer | 1.8yrs | no data | 0.019% ¥ 3.4m | |
| Head of Pharmaceutical Wholesale Business & Director | 10.4yrs | no data | 0.047% ¥ 8.4m | |
| GM of Administration Headquarters & Management Division and Director | 1.8yrs | no data | no data | |
| Pharmacy Business Manager & Director | 1.4yrs | no data | no data | |
| Senior Executive Officer & Chief Director of IT Strategy Headquarters | 5.3yrs | no data | no data | |
| Senior Executive Officer & CEO of the Management Headquarters | 1.4yrs | no data | no data |
1.8yrs
Average Tenure
60yo
Average Age
Experienced Management: 3055's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 18.2yrs | no data | 0.11% ¥ 20.3m | |
| ICT Business Manager | 18.2yrs | no data | 1.76% ¥ 312.3m | |
| Head of Pharmaceutical Wholesale Business & Director | less than a year | no data | 0.047% ¥ 8.4m | |
| GM of Administration Headquarters & Management Division and Director | 1.8yrs | no data | no data | |
| Pharmacy Business Manager & Director | less than a year | no data | no data | |
| Chairman of the Board | 18.2yrs | no data | 1.57% ¥ 278.5m | |
| External Auditor | 18.2yrs | no data | 0.057% ¥ 10.1m | |
| Director | less than a year | no data | 0.057% ¥ 10.1m | |
| Director | less than a year | no data | 0.028% ¥ 5.1m | |
| 2.8yrs | no data | no data | ||
| Independent Outside Director | 1.4yrs | no data | no data |
1.8yrs
Average Tenure
63yo
Average Age
Experienced Board: 3055's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.